207 related articles for article (PubMed ID: 11274279)
1. C-reactive protein and chronic Chlamydia pneumoniae infection--long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis.
Haubitz M; Brunkhorst R
Nephrol Dial Transplant; 2001 Apr; 16(4):809-15. PubMed ID: 11274279
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis.
Paniagua R; Frías Y; de Ventura MJ; Rodríguez E; Hurtado ME; Alcántara G; Vázquez R; Ortiz R; Salcedo M; Rios ME; Kaji J; Amato D
Perit Dial Int; 2003; 23(2):132-7. PubMed ID: 12713079
[TBL] [Abstract][Full Text] [Related]
3. Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients.
Haubitz M; Votsch K; Woywodt A; Nashan B; Groh A; Haller H; Brunkhorst R
Transplantation; 2004 May; 77(10):1517-21. PubMed ID: 15239614
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
[TBL] [Abstract][Full Text] [Related]
5. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker.
Jha HC; Prasad J; Mittal A
Heart Vessels; 2008 Nov; 23(6):390-6. PubMed ID: 19037586
[TBL] [Abstract][Full Text] [Related]
6. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity.
Stenvinkel P; Heimbürger O; Jogestrand T
Am J Kidney Dis; 2002 Feb; 39(2):274-82. PubMed ID: 11840367
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
[TBL] [Abstract][Full Text] [Related]
8. Chlamydial infection and progression of carotid atherosclerosis in patients on regular haemodialysis.
Kato A; Takita T; Maruyama Y; Hishida A
Nephrol Dial Transplant; 2004 Oct; 19(10):2539-46. PubMed ID: 15280523
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients.
Wolf SC; Mayer O; Jürgens S; Vonthein R; Schultze G; Risler T; Brehm BR
Clin Nephrol; 2003 Apr; 59(4):273-9. PubMed ID: 12708567
[TBL] [Abstract][Full Text] [Related]
10. Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
Nabipour I; Vahdat K; Jafari SM; Amiri M; Shafeiae E; Riazi A; Amini AL; Pazoki R; Sanjdideh Z
Heart Lung Circ; 2007 Dec; 16(6):416-22. PubMed ID: 17974477
[TBL] [Abstract][Full Text] [Related]
11. Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease.
Lajunen T; Vikatmaa P; Bloigu A; Ikonen T; Lepäntalo M; Pussinen PJ; Saikku P; Leinonen M
Innate Immun; 2008 Dec; 14(6):375-82. PubMed ID: 19039061
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
[TBL] [Abstract][Full Text] [Related]
13. Association between seroprevalence of anti-chlamydial antibodies and long-term cardiovascular mortality in chronic hemodialysis patients.
Kato A; Takita T; Furuhashi M; Maruyama Y; Hishida A
Atherosclerosis; 2006 Sep; 188(1):120-5. PubMed ID: 16288759
[TBL] [Abstract][Full Text] [Related]
14. [Study on the correlation of between infection, inflammation and coronary artery disease].
Cai XJ; Cai HB; Lu D
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
[TBL] [Abstract][Full Text] [Related]
15. Relevance of C-reactive protein levels in peritoneal dialysis patients.
Fine A
Kidney Int; 2002 Feb; 61(2):615-20. PubMed ID: 11849404
[TBL] [Abstract][Full Text] [Related]
16. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.
Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Fermo I; Focà A; Paroni R; Malatino LS
J Hypertens; 2000 Sep; 18(9):1207-13. PubMed ID: 10994751
[TBL] [Abstract][Full Text] [Related]
17. Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases.
Turkoglu C; Sonmez E; Aydinli A
New Microbiol; 2004 Jul; 27(3):229-34. PubMed ID: 15460525
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).
Zoccali C; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Benedetto FA; Bonanno G; Seminara G; Fatuzzo P; Rapisarda F; Malatino LS
Kidney Int; 2003 Aug; 64(2):579-84. PubMed ID: 12846753
[TBL] [Abstract][Full Text] [Related]
19. Influence of Chlamydia pneumoniae infection on aortic stiffness in healthy young men.
Tasaki N; Nakajima M; Yamamoto H; Imazu M; Okimoto T; Otsuka M; Shimizu Y; Kohno N
Atherosclerosis; 2003 Nov; 171(1):117-22. PubMed ID: 14642413
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae antibodies and markers of inflammation in patients with cardiovascular diseases.
Kazar J; Kovacova E; Koncova K; Cvachova S; Mongiellova V; Lietava J; Simko F
Bratisl Lek Listy; 2005; 106(11):341-4. PubMed ID: 16541617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
